ATE485050T1 - Verwendung von p43 zur förderung der wundheilung - Google Patents

Verwendung von p43 zur förderung der wundheilung

Info

Publication number
ATE485050T1
ATE485050T1 AT03016724T AT03016724T ATE485050T1 AT E485050 T1 ATE485050 T1 AT E485050T1 AT 03016724 T AT03016724 T AT 03016724T AT 03016724 T AT03016724 T AT 03016724T AT E485050 T1 ATE485050 T1 AT E485050T1
Authority
AT
Austria
Prior art keywords
wound healing
polypeptide
promote wound
epithelialization
monocyte
Prior art date
Application number
AT03016724T
Other languages
English (en)
Inventor
Sunghoon Kim
Original Assignee
Atyr Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atyr Pharma Inc filed Critical Atyr Pharma Inc
Application granted granted Critical
Publication of ATE485050T1 publication Critical patent/ATE485050T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
AT03016724T 2002-07-22 2003-07-22 Verwendung von p43 zur förderung der wundheilung ATE485050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0042858A KR100515016B1 (ko) 2002-07-22 2002-07-22 p43을 유효성분으로 하는 창상 치료용 약학적 조성물

Publications (1)

Publication Number Publication Date
ATE485050T1 true ATE485050T1 (de) 2010-11-15

Family

ID=29997531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03016724T ATE485050T1 (de) 2002-07-22 2003-07-22 Verwendung von p43 zur förderung der wundheilung

Country Status (5)

Country Link
US (4) US7282208B2 (de)
EP (1) EP1384486B1 (de)
KR (1) KR100515016B1 (de)
AT (1) ATE485050T1 (de)
DE (1) DE60334589D1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 p43을 유효성분으로 하는 창상 치료용 약학적 조성물
EP1848395A4 (de) * 2005-02-01 2012-06-06 Atyr Pharma Inc Verfahren zur stimulierung der collagensynthese und/oder kgf-expression
AU2006335748A1 (en) 2006-01-23 2007-07-26 Imagene Co., Ltd. Novel peptide and use thereof
WO2008007818A1 (en) * 2006-07-13 2008-01-17 Seoul National University Industry Foundation Novel use of aimp1 for controlling glucose level
JP2010526527A (ja) * 2007-02-01 2010-08-05 イマジーン・カンパニー・リミテッド 抗腫瘍活性を有する新規なポリペプチド
KR101067817B1 (ko) * 2008-10-10 2011-09-27 서울대학교산학협력단 Aimp1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물
ES2552773T3 (es) 2009-02-27 2015-12-02 Atyr Pharma, Inc. Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
JP5730280B2 (ja) 2009-03-16 2015-06-03 パング バイオファーマ リミテッド 非カノニカル生物学的活性を有するヒスチジル−tRNAシンテターゼスプライスバリアントを含む組成物および方法
ES2535951T3 (es) 2009-12-11 2015-05-19 Atyr Pharma, Inc. Histidil ARNt sintetasas para reducir la inflamación
EP2593126B1 (de) 2010-07-12 2017-09-20 aTyr Pharma, Inc. Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von histidyl-trna-synthetasen
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
CN104220461A (zh) 2011-12-29 2014-12-17 Atyr医药公司 天冬氨酰-tRNA合成酶-FC缀合物
EP2814514B1 (de) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
CN114717206A (zh) 2013-03-15 2022-07-08 Atyr 医药公司 组氨酰-trna合成酶-fc缀合物
JP6521995B2 (ja) 2014-02-20 2019-05-29 ユニヴァーシティー オブ ノートル ダム デュ ラック 選択的マトリックスメタロプロテイナーゼ阻害剤
WO2016044844A1 (en) 2014-09-19 2016-03-24 University Of Notre Dame Du Lac Acceleration of diabetic wound healing
ES2994451T3 (en) 2017-04-20 2025-01-24 Atyr Pharma Inc Compositions for treating lung inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
CA2340468A1 (en) * 1998-11-13 2000-05-25 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
AU5114000A (en) * 2000-06-14 2001-12-24 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
KR100405919B1 (ko) * 2001-06-05 2003-11-14 주식회사 이매진 p43의 N-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 p43을 유효성분으로 하는 창상 치료용 약학적 조성물

Also Published As

Publication number Publication date
EP1384486A1 (de) 2004-01-28
DE60334589D1 (de) 2010-12-02
US7282208B2 (en) 2007-10-16
US20080064627A1 (en) 2008-03-13
US20100041608A1 (en) 2010-02-18
EP1384486B1 (de) 2010-10-20
US7572452B2 (en) 2009-08-11
US7981426B2 (en) 2011-07-19
KR20040009048A (ko) 2004-01-31
KR100515016B1 (ko) 2005-09-15
US20120010141A1 (en) 2012-01-12
US20050119175A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
DE60334589D1 (de) Verwendung von p43 zur Förderung der Wundheilung
ATE540973T1 (de) Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE69018920D1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
DK2107109T3 (da) Rekombinant vaskulær endotelcelle-vækstfaktor D (VEGF-D)
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
DK1032671T3 (da) Mammalt cytokin-lignende polypeptid-10
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE382685T1 (de) Bakteriophagen-lysin
DE69132530D1 (de) Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf)
DE68929430D1 (de) Fibronektin bindendes Protein
DE50015938D1 (de) Polypeptidvarianten mit erhoehter heparin-bindungsfaehigkeit
DE60234822D1 (de) Lipoxygenase-varianten und ihre verwendung
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DE69821793D1 (de) Neuronale verwendungen des bmp-11
ATE482272T1 (de) Zytokinproteinfamilie
ES2177625T3 (es) Citoquina cc-1 humana circulante.
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE602004023340D1 (de) Onkogen, davon abgeleitetes rekombinantes Protein und dessen Verwendung
NO20001077L (no) Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister
ATE251640T1 (de) Neues chondrozytprotein
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties